ArticleJournal of thoracic disease2026
Examined lymph node counts ≤6 are correlated with an unfavorable prognosis in stage IA NSCLC patients following sublobar resection: a retrospective study employing propensity score matching analysis.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complete lymph node dissection improves staging accuracy in non-small cell lung cancer (NSCLC) patients and may improve outcomes in select patients. However, the benefit of increased lymph node examination in patients with stage IA NSCLC remains unclear. Therefore, this study aimed to explore the relationship between the examined lymph node (ELN) counts and the prognosis of patients with stage IA NSCLC following sublobar resection. Methods: We obtained data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry study database (2010-2019), including patients with stage IA NSCLC who underwent sublobar resection. Patients with missing ELN counts were excluded. Cox regression analysis showed a correlation between ELN count and cancer-specific survival (CSS). Propensity score matching (PSM) compared survival between ELN ≤6 and ELN >6 groups. Analysis used Empower Stats and R software. Results: In this study, 5,851 patients with NSCLC and pathological stage IA disease were included. Patients with more than 6 ELNs were older, more likely to be Caucasian, and more likely to have lung adenocarcinoma. After PSM, baseline characteristics were balanced between ELN groups. Univariate analysis showed better survival in the ELN >6 group, with a hazard ratio (HR) of 0.75 [95% confidence interval (CI): 0.64-0.88, P=0.0004], which was consistent in multivariate analysis (HR: 0.76, 95% CI: 0.64-0.89, P=0.0008). Kaplan-Meier survival curves indicated significantly better survival in the ELN >6 group, consistent across wedge and segmental resection subgroups. Conclusions: In conclusion, our findings indicate that an ELN count of ≤6 following sublobar resection in patients with stage IA NSCLC is linked to an unfavorable prognosis. We recommend dissecting more than 6 nodes during sublobar resections in stage 1A NSCLC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.